The Joseph Henry Press, an imprint of the National Academy Press, was created with the goal of making books on science, technology, and health more widely available to profes- sionals and the public.

Andy Lin talks about his role at the major biotech company and his role as a mentor on the Industrial Advisory Board (IAB) for Northwestern Engineering's Master of Biotechnology Program (MBP). Andy ...

Karen Lucatero presents the Colombian Case Study at UNIDO Headquarters in Vienna in December 2019. Karen Lucatero's passion for helping people has taken her from a biotechnology engineering background ...

Yarrowia lipolytica has emerged as a versatile yeast platform for biotechnological applications ranging from biofuel synthesis to high-value chemical production. Its oleaginous nature and robust ...

The ability of scientists to rationally engineer organisms using synthetic biology, or “engineering biology” as I prefer to call it, has progressed greatly since high throughput molecular biology ...

In a small laboratory in Northbrook, Illinois, a team of scientists is trying to define the future of medicine. They aren't mixing chemicals in beakers or peering through microscopes. Instead, they ...

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...

General Motors is reducing production at its flagship Factory Zero amid weaker electric vehicle demand, while ImmunityBio has secured approvals to restart its Dunkirk facility for manufacturing its ...

Cutting-edge cellular engineering firm, MaxCyte, has developed a platform, which enables modifications to cells. Applications of MaxCyte's cellular engineering platform are far-reaching, such as ...

- Company also Establishes New Site Leadership Team at Cambridge Facility - GAITHERSBURG, Md., Dec. 20 -- Continuing the solidification of its role as the global biologics unit for AstraZeneca plc (AZ ...

HANGZHOU, China--(BUSINESS WIRE)--Qihan Biotech, a leader in applying multiplexable genome-editing technology to cell therapies and organ transplantation, today published research reporting the ...